Although these findings raise the possibility that BACE1 inhibitors, developed to treat Alzheimer's disease, could be used to treat T2DM, these inhibitors unfortunately enhanced impairment of cognitive/memory processes in Alzheimer patients. The gene discussed is BACE1; the disease is type 2 diabetes mellitus.